Skip to main navigation Skip to search Skip to main content

Design and synthesis of glyco-peptides as anti-cancer agents targeting thrombin-protease activated receptor-1 interaction

  • Yu Hsuan Chang
  • , Jen Chine Wu
  • , Hui Ming Yu
  • , Hua Ting Hsu
  • , Ying Ta Wu
  • , Alice Lin Tsing Yu
  • , Cheng Der Tony Yu
  • , Chi Huey Wong*
  • *Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

4 Scopus citations

Abstract

Thrombin activates protease-activated receptor-1 (PAR-1) through binding to exosite I and the active site to promote tumor growth. We have developed a new class of anti-cancer glyco-peptides to target exosite I selectively without affecting the active-site-mediated coagulation activity and showed the importance of glycans for the stability and anti-cancer activity of the glyco-peptides.

Original languageEnglish
Pages (from-to)5827-5830
Number of pages4
JournalChemical Communications
Volume56
Issue number43
DOIs
StatePublished - 28 05 2020

Bibliographical note

Publisher Copyright:
© The Royal Society of Chemistry 2020.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Design and synthesis of glyco-peptides as anti-cancer agents targeting thrombin-protease activated receptor-1 interaction'. Together they form a unique fingerprint.

Cite this